Results 161 to 170 of about 6,757 (189)
Some of the next articles are maybe not open access.

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

Nature Immunology, 2022
CD40 signaling in classical type 1 dendritic cells (cDC1s) is required for CD8 T cell-mediated tumor rejection, but the underlying mechanisms are incompletely understood. Here, we identified CD40-induced genes in cDC1s, including Cd70, Tnfsf9, Ptgs2 and Bcl2l1, and examined their contributions to anti-tumor immunity.
Renee Wu   +13 more
openaire   +2 more sources

cDC1 to cDC2: “Everything I do, Ido1 it for you”

Immunity, 2022
Distinct dendritic cell (DC) subsets exert specific functions in immune regulation, but their communication with each other has remained elusive. In this issue of Immunity, Gargaro et al. identify the IDO1-Kyn-AHR axis as a metabolic signaling pathway through which conventional DC subsets communicate and induce tolerogenicity.
Mirja Tamara, Prentzell   +1 more
openaire   +2 more sources

cDC1 and cancer

Science, 2020
Tumor Immunology A subset of immune cells called conventional dendritic cell 1 (cDC1) has been shown to play a critical role in antitumor responses. Hubert et al. now show that human cDC1 contribute to antitumor responses through the production of type III interferon, also known as IFN-γ1.
openaire   +1 more source

Doping cDC1s for tolerance

Immunity
Type 1 conventional dendritic cells (cDC1s) are key antigen-presenting cells and have been implicated in the induction of peripheral tolerance, yet how cDC1s actively enforce immune tolerance remains unclear. In a recent issue of Nature, Zhang et al. propose that erythropoietin receptor signaling biases cDC1s toward a maturation state associated with ...
Victor, Bosteels, Sophie, Janssens
openaire   +2 more sources

Cryptic activation of an Irf8 enhancer governs cDC1 fate specification [PDF]

open access: yesNature Immunology, 2019
Induction of the transcription factor Irf8 in the common dendritic cell progenitor (CDP) is required for classical type 1 dendritic cell (cDC1) fate specification, but the mechanisms controlling this induction are unclear. In the present study Irf8 enhancers were identified via chromatin profiling of dendritic cells and CRISPR/Cas9 genome editing was ...
Swapneel Patel   +2 more
exaly   +3 more sources

Who on IRF are you? IRF8 deficiency redirects cDC1 lineage commitment

Trends in Immunology, 2022
Interferon regulatory factor 8 (IRF8) has long been associated with conventional dendritic cell type I (cDC1) development. In a recent study, Lança et al. demonstrate that IRF8 is also crucial in cells already committed to the cDC1 lineage. Here, deletion of IRF8 from the XCR1-expressing pre-cDC1 stage onward leads to a loss of commitment and ...
Waller, Kathryn, Scott, Charlotte L.
openaire   +2 more sources

IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression

Cellular Immunology, 2022
Dendritic cells (DCs) play central role in innate as well as adaptive immune responses regulated by diverse DC subtypes that vary in terms of surface markers, transcriptional profile and functional responses. Generation of DC diversity from progenitor stage is tightly regulated by complex molecular inter-play between transcription factors.
Kuldeep Singh Chauhan   +6 more
openaire   +2 more sources

The Making of a cDC1 : Precision Programming of Progenitor Potential

Immunological Reviews
ABSTRACT The development of type 1 classical dendritic cells (cDC1s) from bone marrow progenitors is a multistage process directed by a complex transcriptional network. At its center is interferon regulatory factor‐8 (IRF8), the lineage‐determining factor whose precise, stage‐specific expression is integrated at ...
Theresa L. Murphy, Kenneth M. Murphy
openaire   +2 more sources

cDC1 craves glutamine for its glory

Nature Immunology, 2023
Stefania Vilbois   +2 more
openaire   +2 more sources

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity

Science
Conventional type 1 dendritic cells (cDC1s) capture antigens in peripheral tissues and migrate to draining lymph nodes (dLNs) to prime antigen-specific CD8 + T cells. How tumor antigens are processed to activate CD8 + T cell immunity is not well ...
Bowen Xie   +18 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy